INTRODUCTION
The pharmaceutical industry has made considerable interest making it a major participant in the healthcare industry. The advances and progress made by pharmaceutical industry have greatly contributed in terms of treat ment of disease, thereby enhancing the quality of life 1 . Amongst the various routes of drug delivery, the oral route is most preferred to the patient and the clinician alike. Ho wever, peroral ad ministration of drugs has Disadvantages such as hepatic first pass metabolism and enzy matic degradation within the gastro intestinal (GIT), that prohibit oral ad ministration of certain classes of drugs especially peptides and proteins. Other absorptive mucosae, are considered as potential site for drug administration. Transmucosal routes of drug delivery (mucosal linings of nasal, rectal, Vag inal, ocular and oral cavity) offers distinct advantages over peroral administration for Systemic drug delivery. These advantages include possible bypass of first pass effect, Avoidances of pre-systemic elimination within GIT and better enzymatic flo ra for drug absorption [1] [2] [3] . In buccal drug delivery, the buccal mucosa is the preferred region as compared to the sublingual mucosa. One of the reasons is that buccal mucosa is less permeable and is thus not able to elicit a rapid onset of absorption and hence better suited for formu lations that are intended for sustained release action. Further, the buccal mucosa being relatively immob ile mucosa and readily accessible, it makes it more advantageous for retentive systems used for oral transmucosal drug delivery. Over the past few decades, the concept of use of bioadhesive polymers to prolong the contact time has gained remarkable attention in transmucosal drug delivery. Adhesion as a process is simp ly defined as the "fixing" of two surfaces to one another. Bioadhesion may be defined as the state in which two materials, at least one of which is biological memb rane, are held together by means of interfacial forces. In the pharmaceutical sciences, when the adhesive attachment is to mucus or a mucous membrane, the phenomenon is referred to as mucoadhesion 4 . Drug absorption into the oral mucosa is main ly via passive diffusion into the lipoidal memb rane. Co mpounds with partition coefficient in the range 40-2000 and pKa 2-10 are considered optimal to be absorbed through buccal mucosa. Co mpounds admin istered by buccal route include steroids, barbiturates, papain, trypsin etc 5 .
In 1980's, Professor Joseph R. Robinson at the University of Wisconsin pioneered the concept of mucoadhesion as a new strategy to prolong the residence time of various drugs on the ocular surface. Mucoadhesive polymers were shown to be able to adhere to various other mucosal memb ranes. The capability to adhere to the mucus gel layer which covers epithelial tissues makes such polymers very useful excip ients in drug delivery 6 . Buccal patches are highly flexible and thus much more readily tolerated by the patient than tablets. Buccal patches are more accurate dosing than gels and ointments 7 . Mucoadhesive drug delivery systems are delivery systems which utilize the
ABS TRACT
Over the last few years Pharmaceutical scientists are trying to explore transdermal and transmucosal routes as an alternative to injections. Buccal delivery of the desired drug using mucoadhesive polymers has been the subject of interest since the early 1980s. Conventional dosage forms for delivery of drugs via the oral mucosa include solutions, erodible or chewable, buccal or sublingual tablets and capsules. Unfortunately, a major portion of the drug in these systems may be unavailable due to involuntary swallowing and a very short residence time, because of mastication, speech etc and hence sustained release is usually not within the scope of such Formulations and development of Novel bioadhesive dosage forms for mucosal delivery of drugs that attempt to overcome these limitations. We formulated buccal drug delivery, the buccal cavity was found to be the most convenient and easily accessible site for the delivery of therapeutic agents for both local and systemic delivery as retentive dosage forms. Because buccal Adhesive drug delivery system prolong the residence time of the dosage form at the site of application or absorption and facilitate an intimate contact of the dosage form with the limited absorption surface and thus contribute to improved better therapeutic efficacy of the drug. Buccal administration of drugs provides a convenient route of administration for both systemic and local drug actions. Buccal drug delivery has gained significant attention and momentum since it offers remarkable advantages. This review article is an overview of buccal drug delivery systems encompassing a review of oral mucosa, active ingredient delivered via buccal route by different mucoadhesive formulations. Including, commercial technologies and future prospects of this route of drug delivery are discussed.
B UCCOADHES IVE DRUG DELIV ERY S YS TEM
The buccal region offers an attractive route of administration for systemic drug delivery. The mucosa has a rich blood supply and it is relatively permeab le. The oral mucosa can be distinguished according to five major regions in the oral cavity.
The buccal mucosa (cheeks)
The gum (gingival)
The palatal mucosa
The inner side of the lips
The floor of the mouth (sublingual region)
In oral cavity, delivery of drugs can be classified into three categories 10 :
Buccal delivery Sublingual delivery Local delivery 
IDEAL CHARACTERISTICS OF B UCCAL DRUG DELIVERY

ADVANTAGES OF B UCCAL DRUG DELIV ERY
Bypass of the gastrointestinal tract and hepatic portal system, increasing the bioavailability of orally administered drugs that otherwise undergo hepatic firstpass metabolism, Imp roved patient compliance due to the elimination of associated pain with injections, Sustained drug delivery and a relatively rapid onset of action can be achieved relative to the oral route and the formu lation can be removed if therapy is required to be discontinued. Increased ease of drug administration, The large contact surface of the oral cav ity contributes to rapid and extensive drug absorption, Extent of perfusion is more therefore quick and effective absorption, nausea and vomiting are greatly avoided. Used in case of unconscious and less cooperative patients. Drugs, which show poor bioavailability via the oral route, can be administered conveniently, ex; drugs which are unstable in the acidic environment of the stomach or are destroyed by the enzy matic or alkaline environment of the intestine 12 , 13,14 .
DISVANTAGES OF MUCOADHES IVE B UCCAL DRUG DELIV ERY
Once placed at the absorption site & the dosage form should not be disturbed. The drug swallo wed in saliva is lost. Properties like unpleasant taste or odour, irritability to the mucosa & stability at salivary pH possess limitations to the choice of drug. Only drugs with small dose can be administered, eating and drinking may become restricted 15, 16 .
MECHANIS M OF B IOADHES ION
Bioadhesion is an interfacial phenomenon in which two materials, at least one of which is biological, are held together by means of interfacial forces. The attach ment could be between an artificial material and biological substrate, such as adhesion between polymer and/or copolymer and a biological membrane. In case of polymer attached to the mucin layer of the mucosal tissue, the term "mucoadhesion" is employed. "Bioadhesive" is defined as a substance that is capable of interacting with biological material and being retained on them or holding them together for extended period of t ime.
In the study of adhesion generally, two steps in the adhesive process have been identified, wh ich have been adapted to describe the interaction between mucoadhesive materials and a mucous membrane as shown below (Fig 1 Different physicochemical interactions happen to combine and toughen the adhesive joint, leading to long-lasting adhesion (Fig 2) . Mucoadhesive materials adhere most strongly to solid dry surfaces as long as they are activated by the presence of moisture and will effectively plasticize the system allo wing mucoadhesive molecules to become free, conform to the shape of the surface and bond predominantly by hydrogen and weaker van der Waal bonding.
Type 3. The Removal Mechanism
Adhesive failure will normally occur at the weakest component of the joint. For weaker adhesives this would be the mucoadhesive-mucus interface, for stronger adhesives this would initially be the mucus layer, but later may be the hydrating mucoadhesive material. The possible regions for mucoadhesive joint failure are shown in 
THEORIES OF B IOADHES ION
Several theories have been proposed to explain the fundamental mechanis m of adhesion.
Wetting theory: Wetting theory is predominantly applicable to liquid bioadhesive systems and analyzes adhesive and contact behavior in terms of a liquid or a paste to spread over a biological system. The work of adhesion (expressed in terms of surface and interfacial tension (γ) being defined as energy per cm 2 released when an interface is formed). According to Dupres equation.
Diffusion theory:
According to this theory, the polymer chains and the mucus mix to a sufficient depth to create a semi-permanent adhesive bond. The exact depth to which the polymer chains penetrate the mucus depends on the diffusion coefficient and the time of contact. This diffusion coefficient, in turn, depends on the value of molecu lar weight between cross links and decreases significantly as the cross linking density decreases.
Electronic theory: According to this theory, electronic transfer occurs upon contact of an adhesive polymer and the mucus glycoprotein network because of differences in their electronic structure. This result in the formu lation of an electronic double layer at the interface adhesion occurs due to attractive forces across the double layer.
Fracture theory: Fracture theory of adhesion is related to separation of two surfaces after adhesion. The fracture strength is equivalent to adhesive strength.
Adsorption theory: According to this theory, after an initial contact between two surfaces, the materials adhere because of surface forces acting between the atoms in the two surfaces. Two types of chemical bonds such as primary covalent (permanent) and secondary chemical bonds (including electrostatic forces, vander Waals forces and hydrogen and hydrophobic bonds) are involved in the adsorption process 18 .
FACTORS AFFECTING B IOADHES ION
Structural and physicochemical properties of a potential bioadhesion material influence bioadhesion.
Polymer related factors
Molecular weight: The bioadhesive force increases with mo lecular weight of polymer up to 10,000 and beyond this level there is no much effect. To allow chain interpenetration, the polymer mo lecule must have an adequate length.
Concentration of active polymers:
There is an optimu m concentration of polymer corresponding to the best bioadhesion. In highly concentrated systems, the adhesive strength drops significantly. In concentrated solutions, the coiled mo lecules become solvent poor and the chains available for interpenetration are not numerous.
Flexibility of polymer chain:
Flexib ility is an important factor for interpenetration and enlargement. As water soluble polymers become cross linked, the mobility of individual poly mer chain decreases. As the cross linking density increases, the effective length of the chain which can penetrate into the mucus layer decreases further and mucoadhesive strength is reduced.
Environment related factors pH:
The pH influences the charge on the surface of both mucus and the polymers. Mucus will have a different charge density depending on pH Because of difference in dissociation of functional groups on the Carbohydrate mo iety and amino acids of the polypeptide back bone.
Strength:
To place a solid bioadhesive system, it is necessary to apply a defined strength.
Initial contact time:
The mucoadhesive strength increases as the initial contact time increases.
Selection of the model substrate surface:
The v iability of biological substrate should be confirmed by examin ing properties such as permeability, Electrophysiology of histology.
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Swelling: Swelling depends on both polymers concentration and on presence of water. When swelling is too great a decrease in bioadhesion occurs.
Physiological variables
Mucin turnover: The natural turnover fro m the mucus layer is important for at least two reasons.
The mucin turnover is expected to limit the residence time of the mucoadhesive on the mucus layers.
Mucin turnover results in substantial amounts of soluble mucin molecu les.
Diseased states: Physicochemical properties of mucus are known to Change during diseased states, such as common cold, gastric ulcers, Ulcerative colitis, cystic fibrosis, bacterial and fungal infect ions of the Female reproductive tract and inflammatory conditions of the eye 19, 20 .
FORMULATIONS FOR B UCCAL DRUG DELIVERY
Buccal adhesive drug delivery systems with the size 1-3 cm 2 and a daily dose of 25 mg or less are preferab le. The maximal duration of buccal delivery is appro ximately 4-6 h.
Buccal adhesive polymers
Mucoadhesive polymers are the important component in the development of buccal delivery systems. These polymers enable retention of dosage form at the buccal mucosal surface and thereby provide intimate contact between the dosage form and the absorbing tissue. These formulat ions are often water soluble and when in a dry form attract water fro m the bio logical surface wh ich in turn leads to a strong interaction between the dosage form and mucosal layer.
An ideal poly mer for a mucoadhesive drug delivery system should have the following characteristics.
The
It should be compatible with the biological membrane 21 . The polymers that are commonly used as Bioadhesive in pharmaceutical applicat ions are in Table. 01 
GEN ERAL CONS IDERATIONS IN FORMULATION DES IGN
Physiological considerations
The designing of buccal dosage form physiological factors such as surface of buccal mucosa, limit ing device size, drug load, thickness of the mucus layer, its turn over time, effect of saliva and other environmental factors are to be considered. Saliva contains certain enzymes (esterases, carbohydrases, phosphatases) that may degrade some drugs. Although saliva secretion facilitates the dissolution of drug, involuntary swallowing of saliva also affects its bioavailability. Saliva has a weak buffering capacity to maintain pH value within local regions. These disadvantages can be avoided by developing unidirectional release systems with backing layer. Th is concept may also results in high drug bioavailability 22 .
Pharmacological considerations
Buccal d rug absorption depends on the partition coefficient of the drugs. Lipophilic drugs absorb through the transcellular route, where as hydrophilic d rugs absorb through the paracellular route. This behaviour leads to the assumption that chemical modification may increase drug penetration through buccal mucosa. Increasing nonionized fraction of ionisable drugs increases drug penetration through trans-cellular route. In weakly basic drugs, the decrease in pH increases the ionic fract ion of drug but decreases its permeability through buccal mucosa. Other pharmacological factors include residence time and local concentration of the drug in the mucosa, treatment of oral diseases, the amount of drug transported across the mucosa into the blood. Similar dependencies on partition coefficients were obtained from acyclovir, β-adrenoreceptor blocking agents and substituted acetanilide 21 .
Pharmaceutical considerations
Factors affecting the drug release, penetration through buccal mucosa, organoleptic factors, and effects of other excip ients used to improve drug release pattern and absorption, irritation caused at the site of application are to be considered while designing a formu lation. Excipients enhancing palatial properties are often required to improve acceptability of dosage form or masking less/desirable properties of the bioactive constituent. Some addit ives can be incorporated to improve drug release pattern and absorption. Ideally pharmaceutical buccal adhesive drug delivery systems should contain mucoadhes ive agents, penetration enhancers and enzyme inhib itors. Mucoadhesive agents are used to maintain an intimate and prolonged contact of the formu lation with the absorption site while penetration enhancers imp rove the drug permeat ion across mucosa (trans -mucosal delivery) or into deepest layers of the epitheliu m (mucosal delivery). The enzy me inhibitors ideally protect the drug from the degradation by means of mucosal enzy mes 21 .
B UCCAL MUCOADHES IVE DOSAGE FORMS
Buccal dosage forms are meant to be placed between gingival and cheek. Buccal adhesive dosage forms are those dosage forms which can deliver drugs either locally to treat conditions within the buccal cavity or systemically via the mucosa. It often requires that buccal-adhesive dosage forms should remain adhesive and allow a controlled delivery of drug for prolonged periods. Therefore, for sustained drug delivery, buccal adhesive formulat ions must contain elements that remain adhesive for a prolonged period, regulate the rate and direction of drug delivery 9, 21, 22 . The different types of Buccoadhesive dosage forms are
Buccal tablets
Buccal tablets are intended to be held in the mouth, where they release their drug contents for absorption directly through the oral mucosa. A buccal tablet may release drug rapidly or may be designed to release drug slowly for a prolonged effect, give improved bioavailability of drug due to avoidance of first-pass metabolism and also improves patient compliance by reducing repetitive dose. Unlike conventional buccal tablets, these tablets can be applied to different sites in the oral cavity, including the palate, the mucosa lining the cheek, as well as between the lip and the gum. Successive tablets can be applied to alternate sides of the mouth. Bioadhesive tablets are usually prepared by direct co mpression, but wet granulation techniques can also be used. Tablets intended for buccal ad ministration by insertion into the buccal pouch may dissolve or erode slowly; therefore, they are formulated and comp ressed with sufficient pressure only to give a hard tablet 23 .
Buccal films
Films are the most recently developed dosage form for buccal administration. Buccal films may be preferred over adhesive tablets in terms of flexibility and comfort. Bioadhesive films are similar to laminated patches in terms of their flexib ility and manufacturing process. They are usually manufactured by a solvent casting method. The drug and polymer(s) are first dissolved in a casting solvent or solvent mixture. The solution is then cast into films, dried and finally laminated with a backing layer o r a release liner. The backing layer helps to retard the diffusion of saliva into the drug layer, thus enhancing the adhesion time and reducing drug loss into the oral cavity. The solvent casting method is simp le, but suffers from some disadvantages, including long processing time, h igh cost and environmental concerns due to the solvents used. These drawbacks can be overcome by the hot-melt extrusion method 24, 25 .
Buccal gels and ointments
Semisolid dosage forms, such as gels and ointments have the advantage of easy dispersion throughout the oral mucosa. Drug dosing from semisolid dosage forms may not be as accurate as from tablets, patches or films. Poor retention of the gels at the site of application has been overcome by using bioadhesive formulations. Certain bioadhesive polymers, e.g. HPM C, polo xamer 407, sodium carboxy methylcellu lose, Carbopol, hyaluronic acid and xanthan gum undergo a phase change from a liquid to a semisolid. Th is change enhances the viscosity, which results in sustained and controlled release of drugs. A highly viscous gel was developed from Carbopol and hydroxyl propyl cellu lose for ointment dosage forms that could be maintained on the tissue for up to 8 h 9, 22 .
Buccal patches
Patches are laminates consisting of an impermeable backing layer, the drug containing reservoir layer fro m which the drug is released in a controlled manner and a bioadhesive surface for mucosal attachment. Buccal patch systems are similar to those used in transdermal drug delivery. Two methods used to prepare adhesive patches include solvent casting and direct milling. In the solvent casting method, the intermediate sheet from wh ich patches are punched is prepared by casting the solution of the drug and polymer(s) onto a backing layer sheet and subsequently allowing the solvent(s) to evaporate. In the direct milling method, formu lation constituents are homogeneously mixed and compressed to the desired thickness and patches of predetermined size and shape are then cut or punched out 24, 25 .
FORMULATION DES IGN
In the case of both mucosal and transmucosal administration, conventional dosage forms are not able to assure therapeutic drug levels on the mucosa and in the circulat ion. This is because of the physiological removal mechanis ms of the oral cavity (washing effect of saliva and mechanical stress), to obtain the therapeutic action, it is therefore necessary to prolong and improve the contact between the active substance and the mucosa. To fu lfill the therapeutic requirements, formulations designed for buccal administration should contain the following functional agents: mucoadhesive agents, to maintain an intimate and prolonged contact of the formu lation with the absorption site; penetration enhancers, to improve drug permeat ion across mucosa (transmucosal delivery) or into deepest layers of the epithelium and enzy me inhib itors, to eventually protect the drug from the degradation by means of mucosal enzy mes 26, 19, 21 .
Mucoadhesive agents
Different situations for buccal mucoadhesion are possible depending on the dosage form. In the case of dry or partially hydrated formulat ions, polymer hydration and swelling properties probably play the main role. The polymer hydration and consequently the mucus dehydration could cause an increase in mucous cohesive properties that promote mucoadhesion. Swelling should favour polymer chain flexibility and interpenetration between polymer and mucin chains. So, depending on the type of formulat ion, poly mers with d ifferent characteristics have to be considered,
The polymers that adhere to the mucin-epithelial surface can be conveniently divided into three broad categories:
Poly mers that become sticky when p laced in water and owe their bio adhesion to Stickiness Poly mers that adhere through nonspecific, noncovalent interactions that are primarily electrostatic in nature Poly mers that bind to specific receptor sites on the cell surface 22 .
Permeation enhancers
Penetration enhancers are also required when a drug has to reach the systemic circulat ion to exert its action. These must be non-irritant and have a reversible effect the epitheliu m should recover its barrier properties after the drug has been absorbed. The most common classes of buccal penetration enhancers include fatty acids (that act by disrupting intercellular lipid packing), surfactants and among these bile salts (by extracting membrane protein or lip ids, by memb rane fluidizat ion, by producing reverse micellization in the membrane and creating aqueous channels), azone (by creating a region of fluidity in intercellular lipids) and alcohols (by reorganizing the lipid domains and by changing protein conformat ion).
Categories and examples of membrane permeation enhancers
Bile salts and other steroidal detergents Surfactants: Non-ionic, Cationic, Anionic Fatty acids Other enhancers: Azones, Salicy lates, Chelat ing agents, Sulfo xides 27 .
Mechanism of buccal absorption enhancer
The mechanism by which enhancers act are been poorly understood. Surfactants such as sodium lauryl sulphate interact at either the polar head groups or the hydrophilic tail regions of the molecules co mprising the lipid bilayer disrupting the packing of the lipid mo lecules, increasing the fluid ity of the bilayer and facilitating drug diffusion. Interaction of enhancers with the polar head groups may also cause or permit the hydrophilic regions of adjacent bilayer to take up more water and more apart, thus opening the par cellular pathway. Non ionic surfactants and long chain acids and alcohols also increase membrane components, thereby increasing the permeability.
Agents such as dimethyl sulfoxide, polyethylene glycol and ethanol, if p resent in sufficient h igh concentrations in the delivery vehicle can enter the aqueous phase of the stratum corneum and alter its solubilising properties, thereby enhancing the partitioning of drugs from the vehicle into the skin.
Mechanisms by which permeation enhancers are thought to improve mucosal absorption include the following.
Changing mucus rheology Increasing fluid ity of lip id bilayer memb rane Affecting the components involved in the formation of intracellular junctions Overco ming the enzy mat ic barrier Increasing the thermodynamic activity of drugs 23, 28, 29 .
MET HOD OF PREPARATION OF MUCOADHES IVE PATCHES
Mucoadhesive buccal patches can be prepared by methods mentioned below; Solvent casting method: Mucoadhesive patches are prepared by solvent casting method. All ingred ients were accurately weighed and mixed in pestle and mortar. Then the mixture added gradually to magnetically stir solvent system, which contain the plasticizer. Continue the stirring until a clear solution is obtained. The solution is then transferred quantitatively to Petri-dish. The Petri-dish covered with inverted funnels to allow evaporation of the solvents. These are kept at 20 -25 ºC temperature for 24 to 48 hours depending upon the solvent system used. Size of patches are 15 to 20 mm diameter, 0.2 to 0.3 mm thick are carefully pull out fro m the Petri dishes 30, 31, 32 .
Semisolid casting:
In semisolid casting method, initially prepare a solution of water soluble film forming poly mer. The resulting solution is added to a solution of acid insoluble polymer (e.g. cellu lose acetate phthalate, cellu lose acetate butyrate), which is prepared in ammon iu m or sodium hydro xide. Then appropriate amount of plasticizer is added so that a gel mass is obtain. Finally the gel mass is cast into the films using heat control drums.
Hot melt extrusion:
In hot melt extrusion method, firstly the drug is mixed with carriers in solid form. Then the extruder containing heaters are used to melt the mixture. In the end, the melt are given the shape of films with the help of dies. Hot melt ext rusion have merit as patches prepared through this method have better content uniformity 33 .
Solid dispersion extrusion:
In this method immiscible components are extruded with drug and then solid dispersions are prepared. Finally the solid dispersions are shaped into films by mean of dies.
Rolling method:
In rolling method a solution or suspension containing drug is rolled on a carrier. So lvent is mainly water and mixture of water and alcohol. Film is dried on the rollers and cut into desired shapes and sizes 34 .
EVALUATION OF B UCCAL PATCHES
Physical properties
Physical appearance and surface texture of patch: Th is parameter was checked simply with visual inspection of patches and evaluation of texture by feel or touch.
Weight uniformity of patches: Th ree patches of the size 10 mm diameter were weighed indiv idually using digital balance and the average weights were calculated.
Thickness of patches:
Thickness of the patches was measured using screw gauge with a least count of 0.01mm at different spots of the patches. The thickness was measured at three different spots of the patches and average was taken 35 .
Folding endurance of patches:
The flexib ility of patches can be measured quantitatively in terms of what is known as folding endurance. Folding endurance of the patches was determined by repeatedly folding a small strip of the patches (approximately 2x2 cm) at the same place till it broke. The number of t imes patches could be folded at the same place without breaking gives the value of fold ing endurance 36 .
Swelling index of patches:
The swelling Index of the patches determined by immersing pre weighed patch of size 2cm2 in 50 ml water. The strip was taken out carefu lly at 5 &10 min. intervals, blotted with filter paper & weighed accurately 36 .
Surface pH of patches: Surface pH was determined by the patches were allowed in contact with 1ml of distilled water. The surface pH was noted by bringing a combined glass electrode or pH paper near the surface of patches and allo wing equilib rating for 1 min.
Mechanical properties
Bursting strength of patches: A test for measuring the resistance of a film to bursting and reported in kilo-Pascal or pounds per square inch or Kg / cm 2 . The bursting strength of all the films were evaluated by using standard bursting strength tester.
In vitro residence time of patches:
The in vitro residence time was determined using IP disintegration apparatus. The disintegration mediu m was 500 mL of simu lated saliva (pH 6.8), maintained at 37 ± 2 ºC. The segments of rat intestinal mucosa, each of 3 cm length, were glued to the surface of a glass slab, which was then vertically attached to the apparatus. Three mucoadhesive films of each formu lation were hydrated on one surface using simu lated saliva (pH 6.8) and the hydrated surface was brought into contact with the mucosal membrane. The glass slab was vertically fixed to the apparatus and allowed to move up and down. The film was completely immersed in the buffer solution at the lowest point and was out at the highest point. The time required for co mplete erosion or detachment of the film fro m the mucosal surface was recorded 37 .
Drug polymer interaction study of patches:
There is always a possibility of drug-excip ient interaction in any formulat ion due to their intimate contact. The technique emp loyed in this study to know drug-excipients interactions is IR spectroscopy; IR spectroscopy is one of the most powerful analytical techniques which offer the possibility of chemical identification. Formu lations were scanned by using Perkin-Elmer FTIR, by a thin film method.
Drug content uni formity of patches: The patches were tested for drug content uniformity by UVSpectrophotometric method. Patches of 10 mm d iameter were cut fro m three d ifferent places fro m the casted patches. Each patch was placed in 100 ml volu metric flask and dissolved in simulated saliva pH 6.8 and 1 mL is taken and diluted with water up to 10 mL. The absorbance of the solution was measured at suitable wavelength using UV/visib le spectrophotometer. The percentage drug content was determined 38 .
In vitro drug release:
In vitro release studies were carried out by attaching sigma d ialysis Membrane to one end of the open cylinder wh ich acted as donor compart ment prepared buccal patches containing drug was placed inside donor compart ment which is agitated continuously using magnetic stirrer and then temperature was maintained at 37 ± 1 ºC. Receptor compart ment consist of 100 mL of pH6.8 simu lated saliva, sample of 2 mL were withdrawn at periodic intervals fro m Receptor compart ment & replaced with fresh phosphate buffer immediately and the drug release was analyzed spectrophotometrically at suitable wave length. Release rate was studied for all designed formulat ions 39 , 40, 41, 42 .
CONCLUS ION
The buccal mucosa offers several advantages for controlled drug delivery for extended periods of time. The mucosa is well supplied with both vas cular and lymphatic drainage and first-pass metabolis m in the liver and presystemic elimination in the gastrointestinal tract are avoided. The area is well suited for a retentive device and appears to be acceptable to the patient. With the right dosage form design and formu lation, the permeab ility and the local environment of the mucosa can be controlled and man ipulated in order to accommodate drug permeation. Buccal drug delivery is a promising area for continued research with the aim of systemic delivery of orally inefficient drugs as well as a feasible and attractive alternative for non-invasive delivery of potent peptide and protein drug molecules. However, the need for safe and effective buccal absorption enhancers is a crucial component for a prospective future in the area of buccal drug delivery.
